Similarly, the expression and significance of FOXO3a, which inhibits nephroblastoma cell proliferation and invasion through down-regulation of the Wnt/β-catenin signaling pathway, presented opportunities for novel therapeutic targets in the management of nephroblastoma [136,137]. Here, FOXO3 is linked to Wilms tumor.